Pre-specified Subgroup Effects

Pre-Specified Subgroup Effects is a type of treatment effect heterogeneity analysis in which the subgroups of interest are defined a priori based on scientific rationale or clinical relevance before the initiation of the study, thereby distinguishing it from data-driven or post hoc subgroup explorations.

141

Publications

13.8K

Citations

852

Authors

506

Institutions

Publications per year

2017–2026

52

Authors

852

  1. IL
    Ilya Lipkovich

    Eli Lilly (United States), United States

    3 publications · 328 citations

    3

    h-index

  2. LG
    Lars G. Hemkens

    University Hospital of Basel, Switzerland

    3 publications · 200 citations

    3

    h-index

  3. MJ
    Mark J. Hancock

    Macquarie University, Australia

    3 publications · 98 citations

    3

    h-index

  4. PJ
    Peter Jüni

    University of Bern, Switzerland

    3 publications · 128 citations

    3

    h-index

  5. DM
    David M. Kent

    Tufts Medical Center, United States

    3 publications · 659 citations

    3

    h-index

1–5 of 852

Venues

  1. Statistics in Medicine

    7 publications · 1.8K citations

    7

    h-index

  2. Clinical Trials

    6 publications · 231 citations

    6

    h-index

  3. Drug Information Journal

    DIA · 4 publications · 94 citations

    4

    h-index

  4. Trials

    4 publications · 716 citations

    4

    h-index

  5. American Heart Journal

    AHJ · 4 publications · 330 citations

    4

    h-index

1–5